FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020128063> ?p ?o ?g. }

• W2020128063 endingPage "481" @default.
• W2020128063 startingPage "475" @default.
• W2020128063 abstract "Abstract Alzheimer's disease (AD) is the most common cause of dementia among people aged 65 and older. In fact, nearly 50% of all people aged 85 and older are thought to have AD. It is thus of high importance to develop therapies to combat the disease and alleviate the devastating outcome. The drugs currently available treat one of the disease symptoms, the decline in acetylcholine, by way of inhibiting the acetylcholinesterase pathway that leads to acetylcholine breakdown. However, this apparently slows the disease symptomology only for a limited time period. Here, neuropeptide/peptide involvement and potential therapy in AD will be approached at several different levels including (1) neuropeptides and AD; (2) amyloid precursor protein processing and toxic beta amyloid (A‐beta) accumulation; (3) peptide vaccination against toxic A‐beta aggregation; (4) peptides in the inhibition of tau phosphorylation and the formation of toxic neurofibrillary tangles; and most emphasis will be placed on (5) neuroprotective peptides, from vasoactive intestinal peptide (VIP) to activity‐dependent neuroprotective protein (ADNP), NAP and activity‐dependent neuroprotective factor (ADNF). Previous studies facilitated the characterization of a lead peptide termed NAP (Asn‐Ala‐Pro‐Val‐Ser‐Ile‐Pro‐Gln, single letter code, NAPVSIPQ). Preclinical experiments show that NAP protects neurons against numerous toxins and cellular stresses including the AD neurotoxin, excitotoxicity, the toxic envelope protein of HIV, electrical blockade, oxidative stress, dopamine toxicity, decreased glutathione, and tumor necrosis factor‐associated toxicity. NAP also has neuroprotective activity in a variety of animal models including the learning‐deficient apolipoprotein E knockout mice (a model related to AD), mouse paradigms of traumatic head injury (risk factor for AD) and fetal alcohol syndrome (oxidative stress), and rat models of cholinotoxicity and stroke. NAP has a short structure, is active at unprecedented low concentrations (femtomolar), is water soluble, bioavailable, easily delivered via intranasal inhalation, and is unusually stable. No NAP toxicity has been observed to date. Thus, NAP is poised to be developed as a novel Alzheimer's disease therapeutic. Drug Dev. Res. 56:475–481 2002. © 2002 Wiley‐Liss, Inc." @default.
• W2020128063 created "2016-06-24" @default.
• W2020128063 creator A5006745559 @default.
• W2020128063 creator A5021078814 @default.
• W2020128063 date "2002-07-01" @default.
• W2020128063 modified "2023-10-06" @default.
• W2020128063 title "Peptides as drug candidates against Alzheimer's disease" @default.
• W2020128063 cites W1573604759 @default.
• W2020128063 cites W1841303832 @default.
• W2020128063 cites W190485934 @default.
• W2020128063 cites W1940428151 @default.
• W2020128063 cites W1964867734 @default.
• W2020128063 cites W1967838681 @default.
• W2020128063 cites W1973385841 @default.
• W2020128063 cites W1976551303 @default.
• W2020128063 cites W1978387914 @default.
• W2020128063 cites W1979302187 @default.
• W2020128063 cites W1983435458 @default.
• W2020128063 cites W1991882458 @default.
• W2020128063 cites W1996556578 @default.
• W2020128063 cites W2000763557 @default.
• W2020128063 cites W2002665813 @default.
• W2020128063 cites W2005863324 @default.
• W2020128063 cites W2007043430 @default.
• W2020128063 cites W2012356006 @default.
• W2020128063 cites W2014174528 @default.
• W2020128063 cites W2014761527 @default.
• W2020128063 cites W2018293456 @default.
• W2020128063 cites W2020778234 @default.
• W2020128063 cites W2026157987 @default.
• W2020128063 cites W2027002271 @default.
• W2020128063 cites W2030011352 @default.
• W2020128063 cites W2035343834 @default.
• W2020128063 cites W2035380213 @default.
• W2020128063 cites W2037024392 @default.
• W2020128063 cites W2038191982 @default.
• W2020128063 cites W2038221712 @default.
• W2020128063 cites W2039744255 @default.
• W2020128063 cites W2042797850 @default.
• W2020128063 cites W2047391965 @default.
• W2020128063 cites W2054695619 @default.
• W2020128063 cites W2059804089 @default.
• W2020128063 cites W2063057075 @default.
• W2020128063 cites W2064863244 @default.
• W2020128063 cites W2065074418 @default.
• W2020128063 cites W2071113270 @default.
• W2020128063 cites W2073394015 @default.
• W2020128063 cites W2073433238 @default.
• W2020128063 cites W2074143348 @default.
• W2020128063 cites W2077986315 @default.
• W2020128063 cites W2081490305 @default.
• W2020128063 cites W2081986231 @default.
• W2020128063 cites W2089828740 @default.
• W2020128063 cites W2090006465 @default.
• W2020128063 cites W2093950048 @default.
• W2020128063 cites W2095566323 @default.
• W2020128063 cites W2099060458 @default.
• W2020128063 cites W2101808673 @default.
• W2020128063 cites W2102340949 @default.
• W2020128063 cites W2105704879 @default.
• W2020128063 cites W2114112734 @default.
• W2020128063 cites W2125063109 @default.
• W2020128063 cites W2126091880 @default.
• W2020128063 cites W2168769697 @default.
• W2020128063 cites W2191007551 @default.
• W2020128063 cites W2333111614 @default.
• W2020128063 cites W2949688224 @default.
• W2020128063 doi "https://doi.org/10.1002/ddr.10103" @default.
• W2020128063 hasPublicationYear "2002" @default.
• W2020128063 type Work @default.
• W2020128063 sameAs 2020128063 @default.
• W2020128063 citedByCount "5" @default.
• W2020128063 countsByYear W20201280632022 @default.
• W2020128063 crossrefType "journal-article" @default.
• W2020128063 hasAuthorship W2020128063A5006745559 @default.
• W2020128063 hasAuthorship W2020128063A5021078814 @default.
• W2020128063 hasConcept C170493617 @default.
• W2020128063 hasConcept C185592680 @default.
• W2020128063 hasConcept C25498285 @default.
• W2020128063 hasConcept C2781012912 @default.
• W2020128063 hasConcept C55493867 @default.
• W2020128063 hasConcept C61174792 @default.
• W2020128063 hasConcept C71924100 @default.
• W2020128063 hasConcept C98274493 @default.
• W2020128063 hasConceptScore W2020128063C170493617 @default.
• W2020128063 hasConceptScore W2020128063C185592680 @default.
• W2020128063 hasConceptScore W2020128063C25498285 @default.
• W2020128063 hasConceptScore W2020128063C2781012912 @default.
• W2020128063 hasConceptScore W2020128063C55493867 @default.
• W2020128063 hasConceptScore W2020128063C61174792 @default.
• W2020128063 hasConceptScore W2020128063C71924100 @default.
• W2020128063 hasConceptScore W2020128063C98274493 @default.
• W2020128063 hasIssue "3" @default.
• W2020128063 hasLocation W20201280631 @default.
• W2020128063 hasOpenAccess W2020128063 @default.
• W2020128063 hasPrimaryLocation W20201280631 @default.
• W2020128063 hasRelatedWork W1503657933 @default.
• W2020128063 hasRelatedWork W2053137874 @default.

• next